Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma

US Patent 10174112 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Treatment of peripheral T cell lymphoma2024
Treatment of peripheral T cell lymphoma2024
Treatment of peripheral T cell lymphoma2024
Treatment with anti-KIR3DL2 agents2024
KIR3DL2 binding agents2024
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2021
Methods for detecting tissue infiltrating NK cells2020